NovaBay Pharmaceuticals Announces Agreement for Nearly $12 Million in Two-Tranche Private Placement
EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY) a biopharmaceutical company focusing on commercializing its Avenova® Lid and Lash Cleanser for the domestic eye care market, announces that it has entered into a securities purchase agreement for the sale of its common stock and warrants in a private placement to accredited investors for $11.791 million. The financing structure is a commitment by investors to participate in two tranches. The first tranche closin
